We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 13, 2022

Cutaneous and Acral Melanoma Cross-OMICs Reveals Prognostic Cancer Drivers Associated With Pathobiology and UV Exposure

Nature Communications


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Communications
Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure
Nat Commun 2022 Jul 15;13(1)4115, ALSA Vicente, A Novoloaca, V Cahais, Z Awada, C Cuenin, N Spitz, AL Carvalho, AF Evangelista, CS Crovador, RM Reis, Z Herceg, V de Lima Vazquez, A Ghantous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading